299 related articles for article (PubMed ID: 28117172)
1. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
[TBL] [Abstract][Full Text] [Related]
2. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
Grenfell RF; Shollenberger LM; Samli EF; Harn DA
Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
[TBL] [Abstract][Full Text] [Related]
3. Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Siegrist CA; Davis HL
FEMS Immunol Med Microbiol; 2001 Apr; 30(3):241-7. PubMed ID: 11335145
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
[TBL] [Abstract][Full Text] [Related]
5. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
[TBL] [Abstract][Full Text] [Related]
6. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.
Guo L; Qiu Y; Chen J; Zhang S; Xu B; Gao Y
Biomed Microdevices; 2013 Dec; 15(6):1077-85. PubMed ID: 23893014
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
[TBL] [Abstract][Full Text] [Related]
8. Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B.
Maheshwari C; Pandey RS; Chaurasiya A; Kumar A; Selvam DT; Prasad GB; Dixit VK
Int Immunopharmacol; 2011 Oct; 11(10):1516-22. PubMed ID: 21609785
[TBL] [Abstract][Full Text] [Related]
9. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
[TBL] [Abstract][Full Text] [Related]
10. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
Xie Y; Sun HX; Li D
Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
Moon SH; Shin EC; Noh YW; Lim YT
Vaccine; 2015 Sep; 33(38):4762-9. PubMed ID: 26271830
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune responses in mice using gamma inulin preparations as adjuvants for hepatitis B vaccines.
Leslie DE; Nicholson S; Dimitrakakis M; Johnston N; Gust ID
Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():107-12. PubMed ID: 1696560
[TBL] [Abstract][Full Text] [Related]
13. Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses.
Savoji MA; Sereshgi MMA; Ghahari SMM; Asgarhalvaei F; Mahdavi M
Int Immunopharmacol; 2021 Jul; 96():107599. PubMed ID: 33848910
[TBL] [Abstract][Full Text] [Related]
14. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
15. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
16. RLJ-NE-299A: a new plant based vaccine adjuvant.
Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
[TBL] [Abstract][Full Text] [Related]
17. Nanogram doses of alum-adjuvanted HBs antigen induce humoral immune response in mice when orally administered.
Kapusta J; Pniewski T; Wojciechowicz J; Bociag P; Płucienniczak A
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):143-51. PubMed ID: 20165988
[TBL] [Abstract][Full Text] [Related]
18. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
[TBL] [Abstract][Full Text] [Related]
19. Novel Biomimetic Reconstituted Built-in Adjuvanted Hepatitis B Vaccine for Transcutaneous Immunization.
Kaurav M; Kumar R; Jain A; Pandey RS
J Pharm Sci; 2019 Nov; 108(11):3550-3559. PubMed ID: 31348940
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to hepatitis B surface antigen following epidermal powder immunization.
Osorio JE; Zuleger CL; Burger M; Chu Q; Payne LG; Chen D
Immunol Cell Biol; 2003 Feb; 81(1):52-8. PubMed ID: 12534946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]